| Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine S Sakuramoto, M Sasako, T Yamaguchi, T Kinoshita, M Fujii, A Nashimoto, ... New England Journal of Medicine 357 (18), 1810-1820, 2007 | 2973 | 2007 |
| Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers T Gotoda, A Yanagisawa, M Sasako, H Ono, Y Nakanishi, T Shimoda, ... Gastric cancer 3, 219-225, 2000 | 2272 | 2000 |
| Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial I Songun, H Putter, EMK Kranenbarg, M Sasako, CJH van de Velde The lancet oncology 11 (5), 439-449, 2010 | 2094 | 2010 |
| Japanese gastric cancer treatment guidelines 2014 (ver. 4) Japanese Gastric Cancer Association jgca@ koto. kpu-m. ac. jp Gastric cancer 20 (1), 1-19, 2017 | 1978 | 2017 |
| Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer K Noda, Y Nishiwaki, M Kawahara, S Negoro, T Sugiura, A Yokoyama, ... New England Journal of Medicine 346 (2), 85-91, 2002 | 1762 | 2002 |
| Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer M Sasako, S Sakuramoto, H Katai, T Kinoshita, H Furukawa, T Yamaguchi, ... J clin oncol 29 (33), 4387-4393, 2011 | 1502 | 2011 |
| D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer M Sasako, T Sano, S Yamamoto, Y Kurokawa, A Nashimoto, A Kurita, ... New England Journal of Medicine 359 (5), 453-462, 2008 | 1293 | 2008 |
| Benefit of adjuvant chemotherapy for resectable gastric cancer a meta-analysis X Paoletti, K Oba, T Burzykowski, S Michiels, Y Ohashi, JP Pignon, ... AMER MEDICAL ASSOC, 2010 | 927 | 2010 |
| Update on the Paris classification of superficial neoplastic lesions in the digestive tract null Endoscopic Classification Review Group Endoscopy 37 (06), 570-578, 2005 | 899 | 2005 |
| Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy—Japan Clinical … T Sano, M Sasako, S Yamamoto, A Nashimoto, A Kurita, M Hiratsuka, ... Journal of clinical oncology 22 (14), 2767-2773, 2004 | 878 | 2004 |
| Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer T Takano, Y Ohe, H Sakamoto, K Tsuta, Y Matsuno, U Tateishi, ... J Clin Oncol 23 (28), 6829-6837, 2005 | 873 | 2005 |
| Randomised trials in surgery: problems and possible solutions P McCulloch, I Taylor, M Sasako, B Lovett, D Griffin Bmj 324 (7351), 1448-1451, 2002 | 849 | 2002 |
| Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions T Sano, T Oyama, K Kashiwabara, T Fukuda, T Nakajima The American journal of pathology 153 (6), 1741-1748, 1998 | 819 | 1998 |
| Identification of Genes Upregulated in ALK-Positive and EGFR/KRAS/ALK-Negative Lung Adenocarcinomas H Okayama, T Kohno, Y Ishii, Y Shimada, K Shiraishi, R Iwakawa, ... Cancer research 72 (1), 100-111, 2012 | 777 | 2012 |
| Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study N Boku, S Yamamoto, H Fukuda, K Shirao, T Doi, A Sawaki, W Koizumi, ... The lancet oncology 10 (11), 1063-1069, 2009 | 737 | 2009 |
| Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial K Fujitani, HK Yang, J Mizusawa, YW Kim, M Terashima, SU Han, ... The Lancet Oncology 17 (3), 309-318, 2016 | 702 | 2016 |
| Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria H Katayama, Y Kurokawa, K Nakamura, H Ito, Y Kanemitsu, N Masuda, ... Surgery today 46, 668-685, 2016 | 668 | 2016 |
| Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a … N Ohuchi, A Suzuki, T Sobue, M Kawai, S Yamamoto, YF Zheng, ... The Lancet 387 (10016), 341-348, 2016 | 589 | 2016 |
| Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric … A Ohtsu, Y Shimada, K Shirao, N Boku, I Hyodo, H Saito, N Yamamichi, ... Journal of clinical oncology 21 (1), 54-59, 2003 | 567 | 2003 |
| Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience Y Nimura, J Kamiya, S Kondo, M Nagino, K Uesaka, K Oda, T Sano, ... Journal of hepato-biliary-pancreatic surgery 7, 155-162, 2000 | 559 | 2000 |
